Medicare Enrolled

Dr. Erin Lally, MD

Ophthalmology · San Jose, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2100 FOREST AVE STE 105, San Jose, CA 95128
4084958800
In practice since 2011 (14 years)
NPI: 1417244831 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lally from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lally? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lally

Dr. Erin Lally is an ophthalmology specialist in San Jose, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Lally performed 1,421 Medicare services across 838 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lally received a total of $4,018 from 22 pharmaceutical and/or device companies across 61 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lally is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 1,421 Medicare services $4,018 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,421
Medicare services
Bottom 43% in CA for ophthalmology
838
Unique beneficiaries
$135
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
432 $111 $325
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
315 $38 $104
Aflibercept eye injection (Eylea) 118 $694 $1,770
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
114 $34 $96
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
88 $116 $307
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
58 $127 $382
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
58 $33 $94
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
43 $27 $70
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
43 $59 $165
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
39 $39 $104
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
37 $10 $28
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
33 $518 $1,334
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $80 $219
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $103 $311
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
43.3% medium
54.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,018
Total received (2018-2024)
Avg $574/year across 7 years
Top 29% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
61
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,924 (72.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,094 (27.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$67
2023
$111
2022
$331
2021
$81
2020
$273
2019
$1,657
2018
$1,499

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$24
Sight Sciences, Inc.
$24
Bausch & Lomb Americas Inc.
$20
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Johnson & Johnson Surgical Vision, Inc.
$1,361
Alimera Sciences, Inc.
$1,255
Regeneron Healthcare Solutions, Inc.
$256
Novartis Pharmaceuticals Corporation
$221
Bausch & Lomb, a division of Bausch Health US, LLC
$130
Alcon Vision LLC
$122
Genentech, Inc.
$111
Genentech USA, Inc.
$104
Regeneron Pharmaceuticals, Inc.
$82
Carl Zeiss Meditec, Inc.
$65
Mallinckrodt Hospital Products Inc.
$45
Bausch & Lomb Americas Inc.
$39
EyePoint Pharmaceuticals US, Inc.
$35
EYEVANCE PHARMACEUTICALS LLC
$26
Horizon Therapeutics plc
$26
Glaukos Corporation
$24
Sight Sciences, Inc.
$24
Aerie Pharmaceuticals, Inc.
$22
Allergan, Inc.
$22
Sun Pharmaceutical Industries Inc.
$20
Allergan Inc.
$18
Oyster Point Pharma, Inc.
$12
Top 3 companies account for 71.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARGOS · BROMSITE · EYLEA · Flarex · HYDRUS Microstent · ILUVIEN · Iluvien · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · Lucentis · MIEBO · OMNI SURGICAL SYSTEM · OZURDEX · Rhopressa · Rocklatan · TEPEZZA · TRAVATAN Z · TYRVAYA · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · VABYSMO · VUITY · VYZULTA · XIIDRA · YUTIQ · iDose
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in San Jose?
Compare ophthalmologists in the San Jose area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
301
Per 100K population
15.8
County median income
$159,674
Nearest hospital
SANTA CLARA VALLEY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lally is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lally experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Lally performed 432 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lally receive payments from pharmaceutical companies?
Yes. Dr. Lally received a total of $4,018 from 22 companies across 61 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lally's costs compare to other ophthalmologists in San Jose?
Dr. Lally's average Medicare payment per service is $135. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lally) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →